[ORGANIZATION]
Hibsago
Featured in 3 tracked stories · first seen
Situations
FDA approval of GSK Hibsago for hepatitis B
2 clusters · 18 sources · last updated
Latest: FDA approves GSK drug Hibsago for chronic hepatitis B
The U.S. Food and Drug Administration (FDA) has approved Hibsago (bepirovirsen), an injectable antisense oligonucleotide developed by GSK, for treating chronic hepatitis B in certain adults. This represents the first FDA
Also covered in
-
FDA approves Hibsago for chronic hepatitis B treatment
[HEALTH] · 2 sources ·